Search
TOPIC IN FOCUS
The latest news and developments that advisors need to create meaningful tax planning strategies for clients.
MORE TO EXPLORE
Expert Perspectives is the home to the voices of industry leaders, as they share their expertise and insights directly from the field.
Discover relevant content from across the suite of ALM legal publications
Media & Resources
Ozempic, Trulicity and Mounjaro were first approved to treat diabetes, however, in the last three years, the FDA has approved rebranded versions of Mounjaro and Ozempic for weight loss, leading demand – and prices – to skyrocket.